Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation

NCT: NCT05820516 · RECRUITING

NCT IDNCT05820516
StatusRECRUITING
Start Date2025-02-01
Completion2027-05

Brief Summary

International Registry to collect patients with severe TR undergoing TricValve implantation from multiple Italian and European centers, aimed at: * Assessing the effect of TricValve implantation on cardiovascular and all-cause mortality, HF rehospitalization, renal function, functional capacity and quality of life. * Clarifying the haemodynamic effects of TricValve implantation and investigating their pathophysiological implications.

Frequently Asked Questions

What is Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation?

Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation is a clinical trial registered under NCT05820516. Current status: RECRUITING.

What is the status of NCT05820516?

The current status of NCT05820516 (Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation) is: RECRUITING.

When did Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation start?

Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation started on 2025-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑